Hemp Stocks & Public Companies


Cannabis firms BR Brands, Dixie to merge hemp, MJ portfolios in $43 million deal

Connecticut-based BR Brands, which owns and distributes a range of marijuana and hemp products, on Monday announced it will merge with Denver-based Dixie Brands in a $43 million reverse takeover. Dixie Brands is a consumer-packaged goods company and manufacturer of cannabis-infused products, including Aceso Hemp, a line of hemp-derived supplements for humans, and Therabis hemp-based […]

Read More

CBD uncertainty in the US market prompts $112M Tilray writedown

Canadian marijuana producer Tilray is lowering the value of its U.S. CBD assets, citing delays from health regulators. Tilray executives reported a $112 million writedown of the value of its 2019 agreement with Authentic Brands Group. The two companies planned to bring CBD products to mass retail outlets, but the lack of direction from the […]

Read More

FDA pledges action against ‘unlawful CBD products’ while offering confidentiality for research

The U.S. Food and Drug Administration said it will continue to “take appropriate action against unlawful CBD products that pose a risk of harm to the public,” even as the federal agency implored the industry to collaborate with the government to study CBD’s possible benefits and dangers. The statement Thursday from new FDA Commissioner Dr. […]

Read More

CBD manufacturer snags $5 million from private equity firm

A New York-based company that makes hemp-derived CBD supplements, drinks and cosmetics has secured $5 million from a European private equity firm in a cash-for-stock deal. Emerald Organic Products, which makes CBD products under the Pura Vida Vitamins label, on Tuesday announced the deal with Bedrock Group Holdings, a private equity firm with offices in […]

Read More

Losses widen for Green Growth Brands as it plans sale of CBD business

Green Growth Brands, an Ohio-based cannabis retailer that owns both marijuana dispensaries and the nation’s largest chain of CBD retail locations in mall kiosks, reported $21.2 million in revenue for the fourth quarter of 2019, up more than 600% from the same period in 2018. The company also announced plans to sell its CBD business […]

Read More

Sports Illustrated, Canopy are latest to chase sports market

Sports Illustrated and Canadian cannabis behemoth Canopy Growth are the latest players looking for a piece of the sports nutrition and recovery market. New York-based Authentic Brands Group, owner of the Sports Illustrated brand, said it will roll out a line of CBD-infused topicals by the end of 2020. And Canopy Growth, majority owner of […]

Read More

Physicians warming to CBD drug for epilepsy, pharmaceutical maker tells investors

Broad physician adoption of a cannabis-derived epilepsy treatment is boosting sales for the only company with federal permission to sell cannabis products in the United States. London-based GW Pharmaceuticals told investors Monday that it notched $108 million in sales last quarter and $309 million for calendar 2019. The sales figures were released in advance of the company’s […]

Read More

Ohio-based CBD empire terminates bid to acquire multistate cannabis operator

Changing economic times have caused an Ohio marijuana and hemp retailer to rethink its latest acquisition. Green Growth Brands, which owns medical marijuana dispensaries and the nation’s largest chain of CBD retail locations in mall kiosks, on Wednesday dropped its $310 million all-stock bid to acquire Moxie Holdings, a Texas-based, privately held, vertically integrated, multistate […]

Read More

Losses increase for Green Growth Brands amid retail expansion

Green Growth Brands, an Ohio-based cannabis retailer that owns both marijuana dispensaries and the nation’s largest chain of CBD retail locations in mall kiosks, reported a loss of $30.2 million for the fiscal first quarter ended Sept. 30. The company lost $2.8 million in the same period a year ago. Company executives attributed the current losses […]

Read More

Charlotte’s Web blames lack of FDA direction for slow revenue growth

CBD giant Charlotte’s Web said slow action by federal health regulators is causing disappointing growth in mass-market retail channels. The Boulder, Colorado, company told investors Wednesday that “a lack of regulatory direction” from the U.S. Food and Drug Administration (FDA) is slowing growth in food, drug and mass (FDM) sales channels. “Full revenue growth potential […]

Read More

Losses narrow for GW Pharmaceuticals on dramatic revenue increase

A strong uptick in doctor prescriptions and coverage from health insurers is being credited for solid quarterly revenues for GW Pharmaceuticals. The London-based firm that makes cannabis-derived CBD medicines reported revenue of $91 million for the third quarter ended Sept. 30, up more than 3,500% from the same period a year ago. Despite the revenue […]

Read More